BIOCRYST PHARMACEUTICALS INC Logo

BIOCRYST PHARMACEUTICALS INC

Develops novel medicines for patients with rare and serious diseases.

BCRX | US

Overview

Corporate Details

ISIN(s):
US09058V1035
LEI:
Country:
United States of America
Address:
4505 EMPEROR BOULEVARD, 27703 DURHAM

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company dedicated to discovering, developing, and commercializing novel medicines for patients with rare and serious diseases. The company's primary focus is on hereditary angioedema (HAE), alongside other rare conditions. BioCryst utilizes its expertise in structure-guided drug design, a process that integrates advanced technologies with biology and medicinal chemistry, to create innovative therapies. It specializes in developing first-in-class or best-in-class oral small-molecule and protein therapeutics, aiming to provide more convenient and effective treatment options for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 08:25
FORM 8-K
English 64.0 KB
2025-12-03 19:40
PRIMARY DOCUMENT
English 8.0 KB
2025-12-03 15:01 English 7.5 KB
2025-12-03 09:00
8-K
English 731.8 KB
2025-12-02 17:14
PRIMARY DOCUMENT
English 6.5 KB
2025-12-02 17:10
PRIMARY DOCUMENT
English 6.6 KB
2025-12-02 17:07
PRIMARY DOCUMENT
English 6.7 KB
2025-12-02 15:09 English 7.5 KB
2025-12-01 13:51 English 6.9 KB
2025-11-25 17:31 English 7.2 KB
2025-11-21 17:29 English 7.0 KB
2025-11-20 18:17
S-4
English 1.0 MB
2025-11-17 17:07
PRIMARY DOCUMENT
English 6.8 KB
2025-11-13 11:21 English 7.1 KB
2025-11-12 21:27 English 12.7 KB

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.